• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-HT2与5-HT1C皮质受体配体选择性的分子结构基础。

Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

作者信息

Pierce P A, Kim J Y, Peroutka S J

机构信息

Department of Neurology, Stanford University School of Medicine, CA 94305.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):4-11. doi: 10.1007/BF00167563.

DOI:10.1007/BF00167563
PMID:1407003
Abstract

A molecular structural criterion of ligand selectivity for the 5-HT2 versus 5-HT1C receptor was hypothesized on the basis of radioligand binding data. Despite the large number of compounds which have been tested at both receptors, analysis of published data led to the identification of only five agents which are greater than 10-fold selective for the 5-HT2 versus the 5-HT1C receptor. Comparison of the two-dimensional structures revealed that, although these five compounds represent three distinct structural classes, they share a common structural feature located in the region hypothesized to be involved in receptor binding: a carbonyl or carboxyl oxygen interposed spatially between an aromatic ring and nitrogen atom. This structural feature was used to predict the relative selectivity of compounds that had not previously been analyzed at both the 5-HT2 and 5-HT1C receptors. All six drugs tested which contain the identified reactive carbonyl or carboxyl group were found to be selective for the 5-HT2 versus the 5-HT1C receptor with selectivity ratios ranging from 26 to 380. By contrast, three agents which are structurally similar but do not contain the reactive carbonyl or carboxyl group displayed equally high affinity for both receptor binding sites. Since the physiological roles of the 5-HT2 and 5-HT1C receptor are markedly different, it would be of potential clinical and scientific value to utilize this molecular structural feature to further identify chemical compounds which would selectively interact with only one of the two receptors.

摘要

基于放射性配体结合数据,推测了5-HT2受体与5-HT1C受体配体选择性的分子结构标准。尽管已有大量化合物在这两种受体上进行了测试,但对已发表数据的分析仅发现了五种对5-HT2受体与5-HT1C受体的选择性大于10倍的药物。二维结构比较显示,虽然这五种化合物代表了三种不同的结构类别,但它们在假定参与受体结合的区域共享一个共同的结构特征:一个羰基或羧基氧在空间上介于一个芳环和氮原子之间。这一结构特征被用于预测此前未在5-HT2和5-HT1C受体上进行分析的化合物的相对选择性。所测试的六种含有已确定的活性羰基或羧基的药物对5-HT2受体与5-HT1C受体具有选择性,选择性比率在26至380之间。相比之下,三种结构相似但不含有活性羰基或羧基的药物对两个受体结合位点显示出同样高的亲和力。由于5-HT2和5-HT1C受体的生理作用明显不同,利用这一分子结构特征进一步鉴定仅选择性地与这两种受体之一相互作用的化合物,可能具有潜在的临床和科学价值。

相似文献

1
Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.5-HT2与5-HT1C皮质受体配体选择性的分子结构基础。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):4-11. doi: 10.1007/BF00167563.
2
High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.高亲和力和低亲和力5-羟色胺2型及5-羟色胺1C型结合位点:对大鼠脑新生期5,7-二氢麦角隐亭损伤的反应
Cytobios. 1993;75(302-303):197-209.
3
Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
J Med Chem. 1992 Dec 25;35(26):4903-10. doi: 10.1021/jm00104a017.
4
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.大鼠脑中(±)-1-(2,5-二甲氧基-4-[¹²⁵I]碘苯基)-2-氨基丙烷([¹²⁵I]DOI)与5-HT₂和5-HT₁c受体结合的放射自显影特征
J Pharmacol Exp Ther. 1990 Nov;255(2):843-57.
5
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
J Med Chem. 1992 Feb 21;35(4):734-40. doi: 10.1021/jm00082a014.
6
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.人类大脑中的血清素受体。II. 5-HT1C和5-HT2识别位点的特征及放射自显影定位
Brain Res. 1986 Jun 18;376(1):97-107. doi: 10.1016/0006-8993(86)90903-0.
7
Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.典型和非典型抗精神病药物与5-HT1C和5-HT2位点的结合:氯氮平与5-HT1C位点有强烈相互作用。
Eur J Pharmacol. 1990 Nov 20;191(1):93-6. doi: 10.1016/0014-2999(90)94100-c.
8
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.用一种新鉴定的5-HT2与5-HT1C选择性拮抗剂对抗1-(2,5-二甲氧基-4-甲基苯基)-2-氨基丙烷刺激。
J Med Chem. 1993 Aug 20;36(17):2519-25. doi: 10.1021/jm00069a010.
9
Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.公认的5-羟色胺2受体拮抗剂在猪脉络丛中对5-羟色胺1C受体的竞争性拮抗作用。
Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):137-42. doi: 10.1007/BF00167210.
10
Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.鉴定修饰配体与5-羟色胺2和5-羟色胺1c血清素受体结合的受体结构域。
Mol Pharmacol. 1992 Oct;42(4):627-33.

引用本文的文献

1
The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.反复给予帕罗西汀对大鼠脑内5-羟色胺受体亚群的影响。
Psychopharmacology (Berl). 1996 Sep;127(1):73-82. doi: 10.1007/BF02805977.
2
Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.5-羟色氨酸、抗精神病药物和5-羟色胺受体拮抗剂在改变啮齿动物对厌恶情境反应中的行为相互作用。
Br J Pharmacol. 1995 Dec;116(7):2989-99. doi: 10.1111/j.1476-5381.1995.tb15954.x.
3
Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

本文引用的文献

1
[(125)I]LSD binding to serotonin and dopamine receptors in bovine caudate membranes.[125I]麦角酰二乙胺与牛尾状核膜中血清素和多巴胺受体的结合。
Neurochem Int. 1985;7(4):699-707. doi: 10.1016/0197-0186(85)90068-3.
2
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.[3H]酮色林(R 41 468),一种用于5-羟色胺2受体结合位点的选择性3H配体。结合特性、脑部分布及功能作用。
Mol Pharmacol. 1982 Mar;21(2):301-14.
3
125I-LSD: a high sensitivity ligand for serotonin receptors.
曲唑酮。对其药理学、在抑郁症中的治疗用途及在其他疾病中的治疗潜力的综述。
Drugs Aging. 1994 Apr;4(4):331-55. doi: 10.2165/00002512-199404040-00006.
125I-麦角酸二乙酰胺:一种用于血清素受体的高灵敏度配体。
Eur J Pharmacol. 1983 May 6;89(3-4):321-2. doi: 10.1016/0014-2999(83)90515-0.
4
[3H]Mesulergine, a selective ligand for serotonin-2 receptors.[3H]美舒麦角,一种5-羟色胺-2受体的选择性配体。
Life Sci. 1983 May 23;32(21):2485-95. doi: 10.1016/0024-3205(83)90375-2.
5
Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.大鼠额叶皮质中125I-麦角酸二乙酰胺与5-羟色胺受体结合的特性研究
J Neurochem. 1984 Sep;43(3):601-6. doi: 10.1111/j.1471-4159.1984.tb12777.x.
6
pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
Life Sci. 1983 Nov 14;33(20):2011-6. doi: 10.1016/0024-3205(83)90740-3.
7
Guanine nucleotides modulate cortical S2 serotonin receptors.
J Recept Res. 1984;4(7):705-12. doi: 10.3109/10799898409041859.
8
The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.血清素能配体与猪脉络丛的结合:一种新型5-羟色胺识别位点的特性
Eur J Pharmacol. 1984 Nov 27;106(3):539-46. doi: 10.1016/0014-2999(84)90057-8.
9
Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.美舒麦角,一种大鼠皮层中的选择性5-羟色胺-2配体,在猪和人类皮层中并不标记这些受体:脑5-羟色胺-2受体存在物种差异的证据。
Eur J Pharmacol. 1984 Nov 27;106(3):531-8. doi: 10.1016/0014-2999(84)90056-6.
10
Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.鸟苷核苷酸和二价阳离子对皮层S2 5-羟色胺受体的调节作用
J Neurochem. 1984 Nov;43(5):1213-9. doi: 10.1111/j.1471-4159.1984.tb05375.x.